Injection Therapy for Neuropathic Pain

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

July 12, 2023

Study Completion Date

July 28, 2023

Conditions
Neuropathic Pain
Interventions
DRUG

Freshly manufactured 35 kDa hyaluronan fragment

"This mixture of high molecular weight HA and hyaluronidase containing 100 mg of HA was locally injected at the pain point or where the nerve trunk innervates the pain point. Then, the pain scale (NPRS) was used to evaluate pain, and the pain relief of patients before and after treatment was recorded.~Each time, according to the amount of high molecular weight HA containing 100 mg HA and hyaluronidase mixture, the pain point area and pain point area of the nerve trunk innervation of the local multipoint injection. Then, the pain scale was used to evaluate pain, and the pain relief of patients before and after treatment was recorded."

Trial Locations (1)

266000

Huinuode Biotechnology Co., Ltd., Qingdao

All Listed Sponsors
lead

Dove Medical Press Ltd

NETWORK

NCT05809700 - Injection Therapy for Neuropathic Pain | Biotech Hunter | Biotech Hunter